Neurona Therapeutics
PrivateLast Round
Early Funding
4/3/2025
Total Funding Raised
$438.8M
Momentum Score
50 /100
Company Overview
Neurona Therapeutics is a biotherapeutics company focused on developing regenerative neural cell therapies with the potential for single-dose cures for chronic neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurona Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Neurona Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | 4/3/2025 | ||||
| Grant | 9/10/2024 | ||||
| Series E | 2/8/2024 | ||||
| Series D | 12/22/2022 | ||||
| Grant | 5/26/2022 | ||||
Series C | 6/22/2021 |
Key People
Founding team and executive leadership
Neurona Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Column Group | Series C, Series A, Series E, Early Funding |
| UCB Ventures | Series C, Series E, Early Funding |
| Soleus Capital | Early Funding |
| SymBiosis Capital Management | Series E |
| Ysios Capital | Early Funding |
| LYFE Capital | Series E, Early Funding |
| Fidelity Management & Research Company | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 23, 2025
Drug-resistant epilepsy candidate NRTX-1001 in two Phase 1/2 trials.
- Nov 18, 2025
Eduardo Dunayevich, M.D. appointed as Chief Medical Officer.
Neurona Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neurona Therapeutics's valuation, stock price, and market status.
